US Stock MarketDetailed Quotes

TIL Instil Bio

Watchlist
  • 24.1300
  • 0.00000.00%
Close Jan 23 16:00 ET
  • 23.4463
  • -0.6837-2.83%
Pre 09:08 ET
157.47MMarket Cap-2.09P/E (TTM)

About Instil Bio Company

Instil Bio, Inc. is a clinical-stage biopharmaceutical company engaged in developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte therapies for the treatment of patients with cancer. The company was founded in August 2018 and is headquartered in Dallas, TX.

Company Profile

SymbolTIL
Company NameInstil Bio
Listing DateMar 19, 2021
Issue Price20.00
Founded2018
CEOMr. Bronson Crouch
MarketNASDAQ
Employees49
Fiscal Year Ends12-31
Address3963 Maple Avenue,Suite 350
CityDallas
ProvinceTexas
CountryUnited States of America
Zip Code75225
Phone1-972-499-3350

Company Executives

  • Name
  • Position
  • Salary
  • Bronson Crouch
  • Chief Executive Officer and Chairman of the Board
  • 1.58M
  • Dr. Sandeep Laumas, M.D.
  • Principal Accounting Officer, Chief Financial Officer and Chief Business Officer
  • 922.92K
  • Dr. Neil Gibson,PhD
  • Lead Independent Director
  • 82.65K
  • Dr. Gwendolyn K. Binder-Scholl, M.D.,PhD
  • Independent Director
  • 57.15K
  • R. Kent McGaughy, Jr
  • Independent Director
  • 66.15K
  • George Matcham, PhD
  • Independent Director
  • 57.15K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.